Light-activated, in situ forming gel for sustained suprachoroidal delivery of bevacizumab

Molecular Pharmaceutics

Volumn 10, Issue 8, 2013, Pages 2858-2867

  Tyagi, Puneet ^a   Barros, Matthew ^a   Stansbury, Jeffrey W ^a   Kompella, Uday B ^a,b,c  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c The University of Colorado Denver   (United States)

Author keywords

bevacizumab; protein delivery; stimuli responsive gel; suprachoroidal delivery; sustained delivery

Indexed keywords

2 HYDROXYETHYL METHACRYLATE; 2,2 DIMETHOXY 2 PHENYLACETOPHENONE; ACETOPHENONE DERIVATIVE; BEVACIZUMAB; POLYCAPROLACTONE; POLYCAPROLACTONE DIMETHACRYLATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CHOROID; CIRCULAR DICHROISM; CONTROLLED STUDY; CROSS LINKING; DRUG ACTIVATION; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; GEL; GEL PERMEATION CHROMATOGRAPHY; IN VIVO STUDY; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; RABBIT; RAT;

ACETOPHENONES; ANIMALS; ANTIBODIES, MONOCLONAL, HUMANIZED; CHROMATOGRAPHY, GEL; CIRCULAR DICHROISM; ENZYME-LINKED IMMUNOSORBENT ASSAY; LIGHT; MAGNETIC RESONANCE SPECTROSCOPY; MICE; POLYESTERS; POLYMERS; RABBITS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84881329600     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp300716t     Document Type: Article

References (56)

1. Wu, L.; Martinez-Castellanos, M. A.; Quiroz-Mercado, H.; Arevalo, J. F.; Berrocal, M. H.; Farah, M. E.; Maia, M.; Roca, J. A.; Rodriguez, F. J. Twelve-month safety of intravitreal injections of bevacizumab (Avastin): results of the Pan-American Collaborative Retina Study Group (PACORES) Graefes Arch. Clin. Exp. Ophthalmol. 2008, 246 (1) 81-7
2. Fung, A. E.; Rosenfeld, P. J.; Reichel, E. The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide Br. J. Ophthalmol. 2006, 90 (11) 1344-9
3. Kim, I. S.; Choi, H. G.; Choi, H. S.; Kim, B. K.; Kim, C. K. Prolonged systemic delivery of streptokinase using liposome Arch. Pharm. Res. 1998, 21 (3) 248-52
4. Sinha, V. R.; Trehan, A. Biodegradable microspheres for protein delivery J. Controlled Release 2003, 90 (3) 261-80
5. Genta, I.; Perugini, P.; Pavanetto, F.; Maculotti, K.; Modena, T.; Casado, B.; Lupi, A.; Iadarola, P.; Conti, B. Enzyme loaded biodegradable microspheres in vitro ex vivo evaluation J. Controlled Release 2001, 77 (3) 287-95
6. Li, Y.; Pei, Y.; Zhang, X.; Gu, Z.; Zhou, Z.; Yuan, W.; Zhou, J.; Zhu, J.; Gao, X. PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats J. Controlled Release 2001, 71 (2) 203-11
7. Andrew, J. S.; Anglin, E. J.; Wu, E. C.; Chen, M. Y.; Cheng, L.; Freeman, W. R.; Sailor, M. J. Sustained Release of a Monoclonal Antibody from Electrochemically Prepared Mesoporous Silicon Oxide Adv. Funct. Mater. 2011, 20 (23) 4168-4174
8. Aimetti, A. A.; Machen, A. J.; Anseth, K. S. Poly(ethylene glycol) hydrogels formed by thiol-ene photopolymerization for enzyme-responsive protein delivery Biomaterials 2009, 30 (30) 6048-54
9. Koutsopoulos, S.; Zhang, S. Two-layered injectable self-assembling peptide scaffold hydrogels for long-term sustained release of human antibodies J. Controlled Release 2012, 160 (3) 451-8
10. Guziewicz, N.; Best, A.; Perez-Ramirez, B.; Kaplan, D. L. Lyophilized silk fibroin hydrogels for the sustained local delivery of therapeutic monoclonal antibodies Biomaterials 2011, 32 (10) 2642-50
11. Cleland, J. L.; Jones, A. J. Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheres Pharm. Res. 1996, 13 (10) 1464-75
12. Kim, H. K.; Park, T. G. Microencapsulation of human growth hormone within biodegradable polyester microspheres: protein aggregation stability and incomplete release mechanism Biotechnol. Bioeng. 1999, 65 (6) 659-67
13. Alonso, M. J.; Gupta, R. K.; Min, C.; Siber, G. R.; Langer, R. Biodegradable microspheres as controlled-release tetanus toxoid delivery systems Vaccine 1994, 12 (4) 299-306
14. Sah, H. Protein behavior at the water/methylene chloride interface J. Pharm. Sci. 1999, 88 (12) 1320-5
15. Sah, H. Protein instability toward organic solvent/water emulsification: implications for protein microencapsulation into microspheres PDA J. Pharm. Sci. Technol. 1999, 53 (1) 3-10
16. Lu, W.; Park, T. G. Protein release from poly(lactic-co-glycolic acid) microspheres: protein stability problems PDA J. Pharm. Sci. Technol. 1995, 49 (1) 13-9
17. Suslick, K. S. The site of sonochemical reactions IEEE Trans. Ultrason. Ferroelectr. Freq. Control 1986, 33 (2) 143-7
18. Bittner, B.; Morlock, M.; Koll, H.; Winter, G.; Kissel, T. Recombinant human erythropoietin (rhEPO) loaded poly(lactide-co-glycolide) microspheres: influence of the encapsulation technique and polymer purity on microsphere characteristics Eur. J. Pharm. Biopharm. 1998, 45 (3) 295-305
19. Zambaux, M. F.; Bonneaux, F.; Gref, R.; Dellacherie, E.; Vigneron, C. Preparation and characterization of protein C-loaded PLA nanoparticles J. Controlled Release 1999, 60 (2-3) 179-88
20. Lentz, B. R.; Madden, S.; Alford, D. R. Transbilayer redistribution of phosphatidylglycerol in small, unilamellar vesicles induced by specific divalent cations Biochemistry 1982, 21 (26) 6799-807
21. Lu, S.; Anseth, K. S. Photopolymerization of multilaminated poly(HEMA) hydrogels for controlled release J. Controlled Release 1999, 57 (3) 291-300
22. Cai, S.; Liu, Y.; Zheng Shu, X.; Prestwich, G. D. Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor Biomaterials 2005, 26 (30) 6054-67
23. Stansbury, J. W.; Dickens, S. H. Network formation and compositional drift during photo-initiated copolymerization of dimethacrylate monomers Polymer 2001, 42 (15) 6363-6369
24. Lee, K. Y.; Mooney, D. J. Hydrogels for tissue engineering Chem. Rev. 2001, 101 (7) 1869-79
25. Christie, J. G.; Kompella, U. B. Ophthalmic light sensitive nanocarrier systems Drug Discovery Today 2008, 13 (3-4) 124-34
26. Aishwarya, S.; Mahalakshmi, S.; Sehgal, P. K. Collagen-coated polycaprolactone microparticles as a controlled drug delivery system J. Microencapsul. 2008, 25 (5) 298-306
27. Goodwin, C. J.; Braden, M.; Downes, S.; Marshall, N. J. Release of bioactive human growth hormone from a biodegradable material: poly(epsilon-caprolactone) J. Biomed. Mater. Res. 1998, 40 (2) 204-13
28. Waknis, V.; Jonnalagadda, S. Novel poly-DL-lactide-polycaprolactone copolymer based flexible drug delivery system for sustained release of ciprofloxacin Drug Delivery 2011, 18 (4) 236-45
29. Lam, C. X.; Savalani, M. M.; Teoh, S. H.; Hutmacher, D. W. Dynamics of in vitro polymer degradation of polycaprolactone-based scaffolds: accelerated versus simulated physiological conditions Biomed. Mater. 2008, 3 (3) 034108
30. Kweon, H.; Yoo, M. K.; Park, I. K.; Kim, T. H.; Lee, H. C.; Lee, H. S.; Oh, J. S.; Akaike, T.; Cho, C. S. A novel degradable polycaprolactone networks for tissue engineering Biomaterials 2003, 24 (5) 801-8
31. Alvarez-Lorenzo, C.; Hiratani, H.; Gomez-Amoza, J. L.; Martinez-Pacheco, R.; Souto, C.; Concheiro, A. Soft contact lenses capable of sustained delivery of timolol J. Pharm. Sci. 2002, 91 (10) 2182-92
32. Moraes, R. R.; Garcia, J. W.; Wilson, N. D.; Lewis, S. H.; Barros, M. D.; Yang, B.; Pfeifer, C. S.; Stansbury, J. W. Improved dental adhesive formulations based on reactive nanogel additives J. Dent. Res. 2012, 91 (2) 179-84
33. Dziubla, T. D.; Torjman, M. C.; Joseph, J. I.; Murphy-Tatum, M.; Lowman, A. M. Evaluation of porous networks of poly(2-hydroxyethyl methacrylate) as interfacial drug delivery devices Biomaterials 2001, 22 (21) 2893-9
34. Hsiue, G. H.; Guu, J. A.; Cheng, C. C. Poly(2-hydroxyethyl methacrylate) film as a drug delivery system for pilocarpine Biomaterials 2001, 22 (13) 1763-9
35. Fine, H. F.; Zhitomirsky, I.; Freund, K. B.; Barile, G. R.; Shirkey, B. L.; Samson, C. M.; Yannuzzi, L. A. Bevacizumab (avastin) and ranibizumab (lucentis) for choroidal neovascularization in multifocal choroiditis Retina 2009, 29 (1) 8-12
36. Bakri, S. J.; Snyder, M. R.; Reid, J. M.; Pulido, J. S.; Singh, R. J. Pharmacokinetics of intravitreal bevacizumab (Avastin) Ophthalmology 2007, 114 (5) 855-9
37. Tyagi, P.; Kadam, R. S.; Kompella, U. B. Comparison of suprachoroidal drug delivery with subconjunctival and intravitreal routes using noninvasive fluorophotometry PLoS One 2012, 7 (10) e48188
38. Patel, S. R.; Lin, A. S.; Edelhauser, H. F.; Prausnitz, M. R. Suprachoroidal drug delivery to the back of the eye using hollow microneedles Pharm. Res. 2011, 28 (1) 166-76
39. Olsen, T. W.; Feng, X.; Wabner, K.; Csaky, K.; Pambuccian, S.; Cameron, J. D. Pharmacokinetics of pars plana intravitreal injections versus microcannula suprachoroidal injections of bevacizumab in a porcine model Invest. Ophthalmol. Vis. Sci. 2011, 52 (7) 4749-56
40. Hill, D. J. T.; Perera, M. C. S.; Pomery, P. Copolymerization of methyl methacrylate and diethylene glycol bis(allyl carbonate) Polymer 1997, 38 (3) 695-702
41. Zhang, L.; Parsons, D. L.; Navarre, C.; Kompella, U. B. Development and in-vitro evaluation of sustained release poloxamer 407 (P407) gel formulations of ceftiofur J. Controlled Release 2002, 85 (1-3) 73-81
42. O'Brart, D. P.; Kwong, T. Q.; Patel, P.; McDonald, R. J.; O'Brart, N. A. Long-term follow-up of riboflavin/ultraviolet A (370 nm) corneal collagen cross-linking to halt the progression of keratoconus Br. J. Ophthalmol. 2013, 97 (4) 433-7
43. Viswanathan, D.; Males, J. Prospective longitudinal study of corneal collagen crosslinking in progressive keratoconus Clin. Exp. Ophthalmol. 2012, 10.1111/ceo.12035
44. Makdoumi, K.; Mortensen, J.; Sorkhabi, O.; Malmvall, B. E.; Crafoord, S. UVA-riboflavin photochemical therapy of bacterial keratitis: a pilot study Graefes Arch. Clin. Exp. Ophthalmol. 2012, 250 (1) 95-102
45. Ferrara, N.; Hillan, K. J.; Novotny, W. Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy Biochem. Biophys. Res. Commun. 2005, 333 (2) 328-35
46. Kliffen, M.; Sharma, H. S.; Mooy, C. M.; Kerkvliet, S.; de Jong, P. T. Increased expression of angiogenic growth factors in age-related maculopathy Br. J. Ophthalmol. 1997, 81 (2) 154-62
47. Bhutto, I. A.; McLeod, D. S.; Hasegawa, T.; Kim, S. Y.; Merges, C.; Tong, P.; Lutty, G. A. Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration Exp. Eye Res. 2006, 82 (1) 99-110
48. Marneros, A. G.; Fan, J.; Yokoyama, Y.; Gerber, H. P.; Ferrara, N.; Crouch, R. K.; Olsen, B. R. Vascular endothelial growth factor expression in the retinal pigment epithelium is essential for choriocapillaris development and visual function Am. J. Pathol. 2005, 167 (5) 1451-9
49. Wang, Y.; Fei, D.; Vanderlaan, M.; Song, A. Biological activity of bevacizumab, a humanized anti-VEGF antibody in vitro Angiogenesis 2004, 7 (4) 335-45
50. Liu, L.; Ammar, D. A.; Ross, L. A.; Mandava, N.; Kahook, M. Y.; Carpenter, J. F. Silicone oil microdroplets and protein aggregates in repackaged bevacizumab and ranibizumab: effects of long-term storage and product mishandling Invest. Ophthalmol. Vis. Sci. 2011, 52 (2) 1023-34
51. Kahook, M. Y.; Liu, L.; Ruzycki, P.; Mandava, N.; Carpenter, J. F.; Petrash, J. M.; Ammar, D. A. High-molecular-weight aggregates in repackaged bevacizumab Retina 2010, 30 (6) 887-92
52. Kunimoto, D. Y.; Kaiser, R. S. Incidence of endophthalmitis after 20- and 25-gauge vitrectomy Ophthalmology 2007, 114 (12) 2133-7
53. Acar, N.; Kapran, Z.; Unver, Y. B.; Altan, T.; Ozdogan, S. Early postoperative hypotony after 25-gauge sutureless vitrectomy with straight incisions Retina 2008, 28 (4) 545-52
54. Low, S. W.; Ng, Y. J.; Yeo, T. T.; Chou, N. Use of Osteoplug polycaprolactone implants as novel burr-hole covers Singapore Med. J. 2009, 50 (8) 777-80
55. Marsh, D. A. Selection of Drug Delivery Approaches for the Back of the Eye: Opportunities and Unmet Needs in Drug Product Development for the Back of the Eye; Springer Sciences: New York, 2011.
56. Qu, J.; Wang, D.; Grosskreutz, C. L. Mechanisms of retinal ganglion cell injury and defense in glaucoma Exp. Eye Res. 2010, 91 (1) 48-53